Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Revenue (2020 - 2025)

Pulse Biosciences (PLSE) has 4 years of Revenue data on record, last reported at $264000.0 in Q4 2025.

  • For Q4 2025, Revenue changed N/A year-over-year to $264000.0; the TTM value through Dec 2025 reached $350000.0, changed N/A, while the annual FY2025 figure was $350000.0, N/A changed from the prior year.
  • Revenue reached $264000.0 in Q4 2025 per PLSE's latest filing, up from $86000.0 in the prior quarter.
  • Across five years, Revenue topped out at $844000.0 in Q4 2021 and bottomed at -$517000.0 in Q2 2021.
  • Average Revenue over 3 years is $204111.1, with a median of $264000.0 recorded in 2025.
  • The widest YoY moves for Revenue: up 13966.67% in 2021, down 2561.9% in 2021.
  • A 3-year view of Revenue shows it stood at $844000.0 in 2021, then plummeted by 101.07% to -$9000.0 in 2022, then soared by 3033.33% to $264000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $264000.0 in Q4 2025, $86000.0 in Q3 2025, and -$9000.0 in Q4 2022.